7. In the table in Schedule 3A to the POM Order(1), (substances which may be prescribed, administered or directed for administration by extended formulary nurse prescribers)—
(a)in column 1 insert, at the appropriate place in the alphabetical order of the entries as they appear in that column, the entry set out in column 1 below, and in column 2, insert, against that entry, the corresponding entry in column 2 below—
| Column 1 | Column 2 |
|---|---|
| Acetylcysteine | Parenteral |
| Adrenaline | Parenteral |
| Alteplase | Parenteral |
| Amiodarone | Parenteral |
| Bemiparin sodium | Parenteral |
| Benzatropine mesilate | Parenteral |
| Calcipotriol | External |
| Calcitriol | External |
| Cefotaxime sodium | Parenteral |
| Ceftriaxone Sodium | Parenteral |
| Certoparin sodium | Parenteral |
| Chlorphenamine maleate | Parenteral |
| Cimetidine | Parenteral |
| Cyclizine hydrochloride | Oral |
| Cyclizine lactate | Parenteral |
| Dalteparin sodicum | Parenteral |
| Dexamethasone sodium phosphate | Oral |
| Dextran 70 | Parenteral |
| Dolesetron mesilate | Oral and parenteral |
| Enoxaparin | Parenteral |
| Furosemide | Oral and parenteral |
| Gelatin 3.5 – 4% | Parenteral |
| Glucose 5% | Parenteral |
| Glucose 5% with Potassium (K+ 40 mmol/L) ready made infusion bag | Parenteral |
| Granisetron hydrochloride | Parenteral |
| Heparin sodium | Parenteral for the purpose of cannulae flushing |
| Hexastarch | Parenteral |
| Human soluble insulin | Parenteral |
| Hydroxyethl starch | Parenteral |
| Levomepromazine | Oral and parenteral |
| Naloxone | Parenteral |
| Omeprazole | Oral |
| Omeprazole sodium | Parenteral |
| Ondansetron Hydrochloride | Oral and parenteral |
| Oxbuprocaine hydrochloride | Ophalmic |
| Pentastarch | Parenteral |
| Prilocaine | External and parenteral |
| Prochlorperazine mesilate | Oral and rectal |
| Prochlorperazine maleate | Oral, rectal and buccal |
| Proxymetacaine hydrochloride | Ophthalmic |
| Reteplase | Parenteral |
| Sodium chloride 0.9% | Parental, for reconstitution of injections and for the purpose of cannulae flushing |
| Sodium chloride 0.9% & Glucose 5% ready made infusion bag | Parenteral |
| Sodium chloride 0.45% & Glucose 5% ready made infusion bag | Parenteral |
| Sodium chloride 0.9% with Potassium (K+ 40 mmol/L) ready made infusion bag | Parenteral |
| Sodium chloride 0.45% and Glucose 5% with Potassium 20mmol per 500 ml ready made infusion bag | Parenteral |
| Streptokinase | Parenteral |
| Tacalcitol | External |
| Tenecteplase | Parenteral |
| Tetanus immunoglobulin | Parenteral |
| Tetracaine | External |
| Tinzaparin sodium | Parenteral |
| Tropicamide | Ophthalmic |
| Tropisetron hydrochloride | Parenteral |
| Unfractionated Heparin | Parenteral |
| Vaccine – Combined Tetanus, diphtheria, acullular pertussis, inactivated poliomyelitis and haemophilus influenza type B | Parenteral |
| Vaccine – Inactivated Poliomyelitis | Parenteral |
| Vaccine – Meningococcal Polysaccharide A, C, W135 and Y | Parenteral |
(b)in the entry for “Beclometasone dipropionate”, in column 2, after “nasal” add “inhalation”;
(c)in the entry for “Budesonide”, in column 2, after “Nasal” add “inhalation”;
(d)omit the entry for “Cyclizine”;
(e)in the entry for “Diazepam”(2), in column 2, omit “in palliative care”;
(f)in the entry for “Diclofenac sodium”(3), in column 2, after “oral” omit “or” and after “rectal” add “or ophthalmic”;
(g)in the entry for “Domperidone”, in column 2, omit “in palliative care”;
(h)in the entry for “Domperidone maleate”, in column 2, omit “in palliative care”;
(i)in the entry for “Flucloxacillin sodium”, in column 2, after “oral” add “or parenteral”;
(j)in the entry for “Hydrocortisone sodium succinate”, in column 2, after “lozenges” add “or parenteral”;
(k)in the entry for “Ipratropium bromide”, in column 2, after “nasal” add “inhalation”;
(l)in the entry for “Lorazepam”(4), in column 2, omit “in palliative care”;
(m)in the entry for “metoclopramide hydrochloride”, in column 2, omit “in palliative care”;
(n)in the entry for “Midazolam”(5), in column 2, omit “in palliative care”;
(o)in the entry for “Ranitidine hydrochloride”, in column 2, after “Oral” insert “or parenteral”.
Schedule 3A was inserted by S.I. 2002/549, and amended by S.I. 2003/696 and 2915, and 2004/2, 1189 and 2693.
The entry for “Diazepam” was inserted by S.I. 2003/2915.
The entry for “Diclofenac Sodium” was inserted by S.I. 2004/2.
The entry for “Lorazepam” was inserted by S.I. 2003/2915.
The entry for “Midazolam” was inserted by S.I. 2003/2915.